TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the […]
Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
There are approximately 3-4 million diagnoses of basal cell carcinomas in the U.S. each year, with a high unmet need […]
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]
RCLCO Ranks Summerlin® and Bridgeland® Among Nation’s Top Five Best-Selling Master Planned Communities of 2023
THE WOODLANDS, Texas, Jan. 05, 2024 (GLOBE NEWSWIRE) — Summerlin® and Bridgeland®, two of the award-winning communities in the Howard […]
ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration
Partnership focused on utilizing Axiomer™ to develop editing oligonucleotides targeting an underlying genetic variant that causes Rett syndrome Collaboration expands […]
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
Immunocore announces strategic priorities and pipeline expansion ahead of 42ndAnnual J.P. Morgan Healthcare Conference presentation Increasing commercial access to KIMMTRAK […]
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity – Associated Inflammation
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company […]
Clean Earth Names New Chief Commercial Officer
KING OF PRUSSIA, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) — Clean Earth, a division of Enviri Corporation (NYSE: NVRI) and […]
Pan American Energy Corp Announces Filing of Inaugural NI 43-101 Technical Report For The Horizon Lithium Project
CALGARY, Alberta, Jan. 05, 2024 (GLOBE NEWSWIRE) — Pan American Energy Corp. (CSE:PNRG) (OTCQB: PAANF) (FRA: SS60) (“Pan American” or […]
Wabash Schedules Fourth Quarter 2023 Earnings Conference Call
LAFAYETTE, Ind., Jan. 05, 2024 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC) today announced that it will webcast its quarterly earnings […]
